semaglutide vs tirzepatide vs wegovy Trial Results Tirzepatide vs. Semaglutide: What the

The first is an over-the-counter supplement marketed to support the bodys natural GLP-1 production

In the Phase 2 Retatrutide trial, dose-dependent increases in heart rate were observed, which peaked at around 24 weeks and declined thereafter

Retatrutide Phase 3 reported up to -28.7% at 68 weeks

Like other peptide-based therapeutics, tirzepatide works by binding to specific cell-surface receptors to trigger biological responses

This led to semaglutide being recommended for diabetics with cardiovascular disease, even before it was widely marketed, and it solidified the idea that GLP-1 RAs have a class benefit on the heart